In this study, the OS of patients with different stages of GC was clearly predicted based on CEACAM6 expression (Fig. 1A–H and Table 1), rather than CEA expression (Supplementary Fig. S1A–E and Table S1). This evidence concerns the gene CEACAM6 and gastric cancer.